Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | Science
▻https://science.sciencemag.org/content/early/2021/01/22/science.abf9302.full
Of course, our maps still do not answer the most pressing question: will SARS-CoV-2 evolve widespread resistance to these antibodies? But certainly, it is concerning that so many escape mutations impose little cost on RBD folding or receptor affinity, and that some are already present at low levels among circulating viruses. Ultimately, it will be necessary to wait and see what mutations spread as #SARS-CoV-2 circulates in the human population. Our work will help with the “seeing,” by enabling immediate interpretation of the effects of the mutations cataloged by viral genomic surveillance.